TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.

Discussions tagged AEFI

User manual for the revised WHO classification for the causality assessment of an adverse event following immunization (AEFI) – Second edition

The second edition of the user manual for the revised WHO classification for the causality assessment of an adverse event following immunization (AEFI) was developed by the WHO with support from the Global Advisory Committee for Vaccine Safety (GACVS). This was based on the findings of a scientific study, “Indo- Zimbabwe inter-country study to assess the inter-rater reliability of the WHO AEFI causality assessment methodology and the utility of the new WHO AEFI causality assessment software” ...

Research proposal guidance: The knowledge & reporting pattern of AEFIs

Goodday colleagues,

I am developing a post-graduate research proposal for submission in an academic institution to improve service delivery and continous quality improvement. The topic isTHE KNOWLEDGE (understanding and perception) OF & REPORTING PATTERN OF ADVERSE EVENTS FOLLOWING IMMUNIZATION (AEFIs) AMONG HEALTH-CARE WORKERS. Its a state-wide intiative and drive and may be scaled up to several other states in NIGERIA if further grants are appoved. I write to request the house to pr...

Multi-dose vaccine in ampoules

Hello All,

In the website for WHO PQ vaccines BCG and Yellow Fever are the two vaccines which have multi dose preparations packaged in ampoules. As soon as we open a mulit-dose ampoule and administer the first dose, we are leaving the remining doses in the ampoule exposed to environment (very often the not so clean undersurface of the vaccine carrier as the opened ampoule is kept in a slit in the top sponge and the VC closed).

Grateful if someone can enlighten me about...

SMS-based AEFI reports

Excerpts from a discussion on another forum about adverse events following immunization (AEFI) data collection. Dhruv wrote: A wise option. Why don't we develop a cellphone-based VAERS? Prabir wrote: See

The global network for the post-marketing surveillance of vaccine

Cross-posted from the January 2012 issue of GIN with thanks.
31/01/2012 from Madhav Balakrishnan, WHO HQ

The Global Network for Post-marketing Surveillance (PMS) of Vaccines was established by WHO in early 2008 with a primary objective to monitor the safety of WHO prequalified vaccines supplied through UN agencies. By 2011, twelve countries, Albania, Brazil, China, India, Iran, Kazakhstan, Mexico, Senegal, Sri Lanka, Tunisia, Uganda and Vietnam have been included in the net...

  • Page :
  • 1